Relaxant effect of transresveratrol on isolated porcine coronary arteries

Arzneimittel-Forschung/Drug Research

Volumn 49, Issue 3, 1999, Pages 207-211

  Jäger, Ulrich ^a   Nguyen Duong, Hoang ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

3,4',5 Trihydroxystilbene; Porcine coronary arteries; Relaxant effects; Trans Resveratrol

Indexed keywords

DRUG RECEPTOR; FLUORIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTAMINE; NITRIC OXIDE; OUABAIN; POTASSIUM CHANNEL; RESVERATROL; TETRYLAMMONIUM; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); POTASSIUM CHANNEL BLOCKING AGENT; STILBENE DERIVATIVE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CELL MEMBRANE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY SPASM; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; GRAPE; ISCHEMIC HEART DISEASE; MORTALITY; NONHUMAN; RISK ASSESSMENT; SWINE; WINE; ANIMAL; CORONARY BLOOD VESSEL; DRUG ANTAGONISM; IN VITRO STUDY; MUSCLE RELAXATION; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FLUORIDES; HISTAMINE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NA(+)-K(+)-EXCHANGING ATPASE; POTASSIUM CHANNEL BLOCKERS; STILBENES; SWINE; TETRAETHYLAMMONIUM COMPOUNDS; VASODILATION; VASODILATOR AGENTS;

EID: 0033090615     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300403     Document Type: Article

References (20)

1. Renaud, S., De Lorgeril, M., Lancet 339, 1523 (1992)
2. Goldberg, D. M., Hahn, S. E., Parkes, J. G., Clin. Chim. Acta 237, 155 (1995)
3. Belguendouz, L., Fremont, L., Linard, A., Biochem. Pharmacol. 53, 1347 (1997)
4. Pace-Asciak, C. R., Hahn, S., Diamandis, E. P. et al., Clin. Chim. Acta 235, 207 (1995)
5. Kimura, Y., Okuda, H., Arichi, S., Biochim. Biophys. Acta 834, 275 (1985)
6. Mannila, E., Talvitie, A., Kolehmainen, E., Phytochemistry 33, 813 (1993)
7. Jang, M., Cai, L., Udeani, G. O. et al., Science 275, 218 (1997)
8. Csokay, B., Prajda, N., Weber, G. et al., Life Sci. 60, 2157 (1997)
9. Ragazzi, E., Froldi, G., Fassina, G., Pharmacol. Res. Comm. 20, (Suppl. V), 79 (1988)
10. Chen, C. K., Pace-Asciak, C. R., Gen. Pharmacol. 27, 363 (1996)
11. Fitzpatrick, D. F., Hirschfield, S. L., Coffey, R. G., Am. J. Physiol. 265, H774 (1993)
12. Nguyen-Duong, H., Arzneim.-Forsch./Drug Res. 35 (II), 1246 (1985)
13. Nguyen-Duong, H., Arzneim.-Forsch./Drug Res. 44 (II), 1013 (1994)
14. Nguyen-Duong, H., in: Advances in Magnesium Research, vol. I, R. Smetana (ed.), John Libbey & Company Ltd., London (1997)
15. Doods, E. C., Goldberg, L., Lawson, W. et al., Proc. Roy. Soc. London (B) 127, 140 (1939)
16. Gehm, B. D., McAndrews, J. M., Chien, P. Y. et al., Proc. Natl. Acad. Sci. USA 94, 14138 (1997)
17. Wehling, M., Ann. Rev. Physiol. 59, 365 (1997)
18. Messerli, F. H., Garavaglia, G. E., Schmieder, R. E. et al., Ann. Inter. Med. 107, 158 (1987)
19. White, R. E., Darkow, D. J., Falvo-Lang, J. L., Circ. Res. 77, 936 (1995)
20. Darkow, D. J., Lu, L., White, R. E., Am. J. Physiol. 272, H2765 (1997)